This inventor holds 4 USPTO granted patents, plus 1 CIPO patent and 2 EPO patents. Top assignees: Nanopharmaceutics, Inc., The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2022-2026.
Company Filing History:
3 out of 5 
1 out of 3,690 
Years Active: 2022-2026
Title: Innovations by Lianhao Zhang: Pioneering Crystalline PRX-3140 Potassium Salt for Alzheimer's Treatment
Introduction
Lianhao Zhang, an esteemed inventor based in Alachua, FL, has made significant contributions to the field of pharmaceuticals, particularly regarding treatments for neurological disorders. With a portfolio of three patents, his work reflects a commitment to enhancing the lives of individuals affected by Alzheimer's disease and other related conditions.
Latest Patents
Lianhao Zhang's latest patent focuses on "Compositions and methods for oral delivery of crystalline PRX-3140 potassium salt." This invention provides innovative crystalline fine particle forms of PRX-3140 potassium salt along with methods for their preparation. The intended treatment targets Alzheimer's disease (AD) and other dementias that involve the cholinergic and serotonergic systems. Notably, the advantages of this crystalline form include improved bioavailability and stability compared to other crystalline or amorphous forms. Additionally, the patent explores oral dosage forms, particle delivery systems (PDS), and final dosage forms, all of which aim to enhance the effectiveness and safety of the treatments.
Career Highlights
Zhang has had a noteworthy career, contributing his expertise to companies such as Nanopharmaceutics, Inc. and The United States of America as represented by the Secretary of the Department of Health and Human Services. His work in these organizations illustrates his dedication to research and development in the pharmaceutical industry, particularly in the area of innovative treatment methodologies.
Collaborations
Throughout his career, Lianhao Zhang has collaborated with esteemed colleagues, including James David Talton and Mianji Zhang. These partnerships have fostered a creative and innovative environment, driving forward valuable research in their respective fields.
Conclusion
In summary, Lianhao Zhang exemplifies the spirit of innovation through his patents, particularly his groundbreaking work on crystalline PRX-3140 potassium salt. His endeavors in pharmaceutical research contribute significantly to the understanding and treatment of Alzheimer's disease and related disorders. With a track record of collaboration and development, Zhang remains a pivotal figure in the advancement of medical science.